Asthma Clinical Trials in District of Columbia

22 recruiting studies across 1 city

Browse by City

All Trials in District of Columbia

Phase

Trial	Phase	Sponsor	Dist.
The Exhale Study: Treating Maternal Depression in an Urban Pediatric Asthma Clinic	N/A	Children's National Research Institute	<1 mi
Registry of Asthma Characterization and Recruitment 3 (RACR3)	—	National Institute of Allergy and Infectious Diseases (NIAID)	<1 mi
Omalizumab Before Onset of Exacerbations	Phase 2	Children's National Research Institute	<1 mi
Protocol CAUSE-03 / CHEETAH	—	National Institute of Allergy and Infectious Diseases (NIAID)	<1 mi
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)	Phase 3	AstraZeneca	<1 mi
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma	Phase 2	Sanofi	<1 mi
Hospital to Home Study: Trial to Optimize Transitions and Address Disparities in Asthma Care	N/A	Kavita Parikh	<1 mi
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma	Phase 3	AstraZeneca	6 mi
A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up	—	National Institute of Allergy and Infectious Diseases (NIAID)	6 mi
Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia	—	National Institute of Allergy and Infectious Diseases (NIAID)	6 mi
Role of Genetic Factors in the Development of Lung Disease	—	National Heart, Lung, and Blood Institute (NHLBI)	6 mi
Y of Central Maryland Head Start Asthma Implementation	—	Johns Hopkins University	9 mi
Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects	—	Biometry Inc	13 mi
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)	Phase 3	Generate Biomedicines	25 mi
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma	Phase 3	Teva Branded Pharmaceutical Products R&D LLC	29 mi
Implementation of Asthma Community Home and School Management Program (Asthma CHAMPS)	N/A	Johns Hopkins University	35 mi
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma	Phase 3	AstraZeneca	35 mi
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)	—	Duke University	35 mi
Metformin IN Asthma for Overweight and Obese Individuals (MINA)	Phase 2	Johns Hopkins University	35 mi
Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma)	Phase 2	Connect Biopharm LLC	46 mi
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids	Phase 2	AstraZeneca	46 mi
A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma	Phase 1	Amgen	46 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.